vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and UDR, Inc. (UDR). Click either name above to swap in a different company.
UDR, Inc. is the larger business by last-quarter revenue ($425.8M vs $236.8M, roughly 1.8× CROSS COUNTRY HEALTHCARE INC). UDR, Inc. runs the higher net margin — 44.6% vs -35.0%, a 79.6% gap on every dollar of revenue. On growth, UDR, Inc. posted the faster year-over-year revenue change (0.9% vs -23.6%). Over the past eight quarters, UDR, Inc.'s revenue compounded faster (1.3% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
UDR, Inc. is a leading U.S.-headquartered real estate investment trust specializing in owning, operating, and redeveloping high-quality multifamily residential apartment communities. It operates across major U.S. metropolitan markets, catering to a diverse tenant base including young professionals, families, and middle-to-high income households.
CCRN vs UDR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $425.8M |
| Net Profit | $-82.9M | $189.8M |
| Gross Margin | — | — |
| Operating Margin | -30.2% | 54.0% |
| Net Margin | -35.0% | 44.6% |
| Revenue YoY | -23.6% | 0.9% |
| Net Profit YoY | -2109.7% | 147.2% |
| EPS (diluted) | $-2.56 | $0.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $425.8M | ||
| Q4 25 | $236.8M | $433.1M | ||
| Q3 25 | $250.1M | $431.9M | ||
| Q2 25 | $274.1M | $425.4M | ||
| Q1 25 | $293.4M | $421.9M | ||
| Q4 24 | $309.9M | $422.7M | ||
| Q3 24 | $315.1M | $420.2M | ||
| Q2 24 | $339.8M | $415.3M |
| Q1 26 | — | $189.8M | ||
| Q4 25 | $-82.9M | $222.9M | ||
| Q3 25 | $-4.8M | $40.4M | ||
| Q2 25 | $-6.7M | $37.7M | ||
| Q1 25 | $-490.0K | $76.7M | ||
| Q4 24 | $-3.8M | $-5.0M | ||
| Q3 24 | $2.6M | $22.6M | ||
| Q2 24 | $-16.1M | $28.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 20.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 20.4% | — | ||
| Q2 24 | 20.8% | — |
| Q1 26 | — | 54.0% | ||
| Q4 25 | -30.2% | 64.1% | ||
| Q3 25 | -2.4% | 17.7% | ||
| Q2 25 | -2.1% | 18.2% | ||
| Q1 25 | -0.3% | 29.0% | ||
| Q4 24 | -1.1% | 15.7% | ||
| Q3 24 | 0.9% | 16.6% | ||
| Q2 24 | -5.7% | 16.5% |
| Q1 26 | — | 44.6% | ||
| Q4 25 | -35.0% | 51.5% | ||
| Q3 25 | -1.9% | 9.4% | ||
| Q2 25 | -2.4% | 8.9% | ||
| Q1 25 | -0.2% | 18.2% | ||
| Q4 24 | -1.2% | -220.5% | ||
| Q3 24 | 0.8% | 5.4% | ||
| Q2 24 | -4.7% | 7.0% |
| Q1 26 | — | $0.63 | ||
| Q4 25 | $-2.56 | $0.67 | ||
| Q3 25 | $-0.15 | $0.12 | ||
| Q2 25 | $-0.20 | $0.11 | ||
| Q1 25 | $-0.02 | $0.23 | ||
| Q4 24 | $-0.13 | $-0.01 | ||
| Q3 24 | $0.08 | $0.06 | ||
| Q2 24 | $-0.47 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $1.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $3.3B |
| Total Assets | $449.0M | $10.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.3M | ||
| Q4 25 | $108.7M | $1.2M | ||
| Q3 25 | $99.1M | $1.2M | ||
| Q2 25 | $81.2M | $1.5M | ||
| Q1 25 | $80.7M | $1.3M | ||
| Q4 24 | $81.6M | $1.3M | ||
| Q3 24 | $64.0M | $2.3M | ||
| Q2 24 | $69.6M | $2.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $5.8B | ||
| Q3 25 | — | $5.8B | ||
| Q2 25 | — | $5.8B | ||
| Q1 25 | — | $5.8B | ||
| Q4 24 | — | $5.8B | ||
| Q3 24 | — | $5.9B | ||
| Q2 24 | — | $5.8B |
| Q1 26 | — | $3.3B | ||
| Q4 25 | $322.8M | $3.3B | ||
| Q3 25 | $408.1M | $3.3B | ||
| Q2 25 | $412.2M | $3.3B | ||
| Q1 25 | $418.2M | $3.3B | ||
| Q4 24 | $419.0M | $3.4B | ||
| Q3 24 | $424.7M | $3.5B | ||
| Q2 24 | $433.3M | $3.7B |
| Q1 26 | — | $10.3B | ||
| Q4 25 | $449.0M | $10.6B | ||
| Q3 25 | $538.2M | $10.6B | ||
| Q2 25 | $553.8M | $10.6B | ||
| Q1 25 | $576.2M | $10.7B | ||
| Q4 24 | $589.3M | $10.9B | ||
| Q3 24 | $597.4M | $11.1B | ||
| Q2 24 | $602.9M | $11.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.77× | ||
| Q3 25 | — | 1.78× | ||
| Q2 25 | — | 1.74× | ||
| Q1 25 | — | 1.74× | ||
| Q4 24 | — | 1.69× | ||
| Q3 24 | — | 1.67× | ||
| Q2 24 | — | 1.55× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | — |
| Free Cash FlowOCF − Capex | $16.1M | — |
| FCF MarginFCF / Revenue | 6.8% | — |
| Capex IntensityCapex / Revenue | 0.9% | 4.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $18.2M | $902.9M | ||
| Q3 25 | $20.1M | $234.9M | ||
| Q2 25 | $4.2M | $250.3M | ||
| Q1 25 | $5.7M | $156.2M | ||
| Q4 24 | $24.2M | $876.8M | ||
| Q3 24 | $7.5M | $230.3M | ||
| Q2 24 | $82.4M | $238.5M |
| Q1 26 | — | — | ||
| Q4 25 | $16.1M | $650.0M | ||
| Q3 25 | $17.9M | $164.6M | ||
| Q2 25 | $2.3M | $190.1M | ||
| Q1 25 | $3.8M | $103.2M | ||
| Q4 24 | $21.7M | $627.0M | ||
| Q3 24 | $6.3M | $161.3M | ||
| Q2 24 | $79.6M | $171.1M |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | 150.1% | ||
| Q3 25 | 7.2% | 38.1% | ||
| Q2 25 | 0.8% | 44.7% | ||
| Q1 25 | 1.3% | 24.5% | ||
| Q4 24 | 7.0% | 148.3% | ||
| Q3 24 | 2.0% | 38.4% | ||
| Q2 24 | 23.4% | 41.2% |
| Q1 26 | — | 4.9% | ||
| Q4 25 | 0.9% | 58.4% | ||
| Q3 25 | 0.9% | 16.3% | ||
| Q2 25 | 0.7% | 14.2% | ||
| Q1 25 | 0.6% | 12.6% | ||
| Q4 24 | 0.8% | 59.1% | ||
| Q3 24 | 0.4% | 16.4% | ||
| Q2 24 | 0.8% | 16.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.05× | ||
| Q3 25 | — | 5.81× | ||
| Q2 25 | — | 6.64× | ||
| Q1 25 | — | 2.04× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | 10.19× | ||
| Q2 24 | — | 8.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
UDR
| Rental income | $423.3M | 99% |
| Joint venture management and other fees | $2.5M | 1% |
